The functional significance of symptomatology and cognitive function in schizophrenia

Schizophrenia Research
Dawn I VelliganAlexander L Miller

Abstract

The relationships between positive and negative symptomatology, cognitive function, and the ability to perform basic activities of daily living in patients with schizophrenia were examined in two studies. In study 1, 112 medicated patients were assessed utilizing the Brief Psychiatric Rating Scale (positive symptoms), the Negative Symptom Assessment (negative symptoms and cognitive function), and the Functional Needs Assessment (activities of daily living). Study 2 (n = 41), utilized the same measures of symptomatology and added a comprehensive neuropsychological test battery. Regression analyses in both studies determined that symptomatology predicts a relatively small amount of the variance in the ability to perform basic activities of daily living. Cognitive function, whether assessed with the Cognition subscale of the Negative Symptom Assessment or a comprehensive neuropsychological test battery, predicted over 40% of the variance in scores on the Functional Needs Assessment. A path model in which cognition predicted both concurrent symptomatology and activities of daily living and where symptomatology had little direct impact upon activities of daily living fit the data. The importance of addressing cognitive deficits in p...Continue Reading

References

Jan 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·E C JohnstoneM Stevens
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·T WykesD Hemsley
Mar 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·T KolakowskaB M Mandelbrote
Jan 1, 1986·Schizophrenia Bulletin·W A Anthony, R P Liberman
Apr 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·T KolakowskaM Ardern
Jul 1, 1984·Comprehensive Psychiatry·J P LindenmayerL Opler
Jan 1, 1984·Schizophrenia Bulletin·M F Pogue-Geile, M Harrow
Jun 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·L Cipolotti, E K Warrington
Jan 1, 1995·Schizophrenia Bulletin·D L PennD Reed
Mar 27, 1995·Psychiatry Research·D I VelliganC V Flores
Aug 1, 1994·Psychiatry Research·P W CorriganR Toomey
Jan 1, 1994·Schizophrenia Bulletin·R H BenedictR F Asarnow

❮ Previous
Next ❯

Citations

Sep 4, 2009·Der Nervenarzt·H-P VolzM Riedel
Jul 17, 2007·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelHans-Jürgen Möller
Nov 9, 2007·European Archives of Psychiatry and Clinical Neuroscience·Andreas WittorfStefan Klingberg
Oct 15, 2009·European Archives of Psychiatry and Clinical Neuroscience·Silvana GalderisiMario Maj
Dec 1, 2007·Community Mental Health Journal·Sunny Ho Wan Chan, Frederick Ka Ching Yeung
Aug 1, 2012·Community Mental Health Journal·Simon ZhornitskyStéphane Potvin
Oct 16, 2012·Community Mental Health Journal·Jens Peter HansenLise Hounsgaard
May 12, 2005·The Psychiatric Quarterly·Claire AdvokatJohn Pickering
Apr 6, 2012·Current Psychiatry Reports·Rebecca SchennachMichael Riedel
Apr 6, 2005·NeuroImage·Venkatasubramanian GanesanSean A Spence
Oct 8, 2004·Schizophrenia Research·Maria SemkovskaEmmanuel Stip
Dec 31, 2002·Psychoneuroendocrinology·S Kasper, E Resinger
Jun 27, 2002·Schizophrenia Research·Dwight Dickinson, Robert D Coursey
Dec 12, 2001·Schizophrenia Research·Dawn I VelliganAlexander L Miller
Nov 5, 2002·Schizophrenia Research·Catherine HughesTonmoy Sharma
Nov 5, 2002·Schizophrenia Research·Frank M J WooningsRobert J van den Bosch
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·T Sharma
Sep 16, 2009·Psychological Medicine·C González-BlanchB Crespo-Facorro
Sep 24, 2010·Psychological Medicine·J W CarterS A Mednick
Mar 24, 2011·Psychological Medicine·A HoferW W Fleischhacker
Jul 14, 2004·Epidemiologia e psichiatria sociale·Paolo Stratta, Alessandro Rossi
Apr 22, 2004·Neuropsychology·Roderick K MahurinDedra Buchwald
Jan 22, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Terry E GoldbergPhilip D Harvey
Sep 17, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tyler A LeshCameron S Carter
Mar 31, 2006·Cognitive Neuropsychiatry·Michi Hatashita-WongDeborah F Willson
Feb 18, 2006·Journal of Clinical and Experimental Neuropsychology·Philip D HarveyKenneth L Davis
Aug 18, 2009·Journal of Clinical and Experimental Neuropsychology·Allen E ThorntonWendy Loken Thornton
Oct 14, 2005·Schizophrenia Bulletin·Philip D HarveyChristopher R Bowie
Apr 28, 2006·Schizophrenia Bulletin·Dawn I VelliganJames M Gold
May 12, 2007·Schizophrenia Bulletin·Philip D HarveyAlan S Bellack
Aug 23, 2008·Schizophrenia Bulletin·Marie Antoinette Redoblado HodgeAnthony Harris
Sep 12, 2009·Schizophrenia Bulletin·R Alison AdcockSophia Vinogradov
Dec 8, 2010·Schizophrenia Bulletin·Dawn I VelliganSanjay Dube
Sep 1, 2011·Schizophrenia Bulletin·Keith H NuechterleinJim Mintz
Jun 24, 2004·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Hélène SchererJean-Pierre Motard
Apr 19, 2003·International Clinical Psychopharmacology·Stéphane PotvinJean-Yves Roy
Sep 10, 2008·Psychiatry and Clinical Neurosciences·Ken YamauchiTetsuro Ohmori
Mar 27, 2012·Psychiatry and Clinical Neurosciences·Mounir OuzirOmar Battas
Nov 8, 2008·Bulletin of the Menninger Clinic·Giampaolo SalvatorePaul H Lysaker
Jun 8, 2012·Drug Design, Development and Therapy·Norio Yasui-Furukori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.